Vinergy Resources (TSE:MBAI) has released an update.
MedBright AI Investments Inc. has unveiled the pricing for its AI product suite, MedMatrix, targeting the significant US outpatient clinic market with a value proposition to enhance clinic revenues by 1-3%. MedMatrix offers a blend of AI-driven analysis for healthcare facilities with a no-upfront-cost model and a free trial to showcase its capabilities. The anticipated growth of the outpatient clinic services market, where MedMatrix will compete, is expected to reach US$1.37 trillion in 2024, making this a notable development for investors and healthcare providers alike.
For further insights into TSE:MBAI stock, check out TipRanks’ Stock Analysis page.
